Single-shot Johnson & Johnson vaccine 66 per cent effective against COVID-19, study shows

Single-shot Johnson & Johnson vaccine 66 per cent effective against COVID-19, study shows

Brisbane Times

Published

The company says its vaccine is 72 per cent effective in preventing COVID-19 in the US but a lower rate of 66 per cent was observed globally in the large trial conducted across three continents.

Full Article